SOLOPHARM organized the production of viscoelastics

SOLOPHARM the company started the production of viscoelastics, solutions, necessary for carrying out surgical interventions on the eyeball. The company noted that SOLOPHARM became the first Russian company that developed technology for the production of viscoelastics based on hyaluronic acid and chondroitin.

The viscoelastics serve to maintain the volume of the anterior chamber of the eye during surgery, performing protective and compensatory functions. To their quality and properties of viscosity, elasticity and transparency high demands. Often the viscoelastics used in the surgical treatment of cataracts.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]